Deerfield Stockholders Approve CareMax and IMC Deal

Deerfield Healthcare Technology
CareMax

Deerfield Healthcare Technology Acquisitions stockholders voted to approve the business combination with CareMax Medical Group and IMC Medical Group Holdings.

Announced in December, the total consideration for CareMax will be approximately $364 million, net of debt. Total consideration to IMC Health equity holders will be $250 million, net of debt.

To sweeten the deal, current CareMax shareholders will be entitled to receive an additional earn out payment of up to 6.4 million shares of CareMax common stock, with 50% of those shares vesting if the stock of the company trades at or above $12.50 during in first 12 months after closing and the balance of the shares will vest if the stock trades at or above $15 during the first 24 months after closing. 

There were no redemptions in connection with the merger vote, the SPAC said. Read more.

Total
0
Shares
Related Posts
OceanTech Acquisitions I
Read More

OceanTech Acquisitions I Pushes Extension Vote to May 30

OceanTech I in February called off a proposed merger with fintech Majic Wheels by mutual agreement and last October terminated a deal with Captura Biopharma. In March, the original management team sold the sponsor holdings to a new team, which three weeks ago announced a definitive merger agreement with Israel-based Regentis Biomaterials at a $95 million valuation.